Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
3,993,068
-
Share change
-
+1,187,353
-
Total reported value
-
$14,891,000
-
Put/Call ratio
-
508%
-
Price per share
-
$3.73
-
Number of holders
-
33
-
Value change
-
+$4,429,302
-
Number of buys
-
16
-
Number of sells
-
9
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q4 2021
As of 31 Dec 2021 DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) had 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,993,068 shares of stock of the company.
Largest 10 holders included Stonepine Capital Management, LLC, VANGUARD GROUP INC, COOPERMAN LEON G, JACOB ASSET MANAGEMENT OF NEW YORK LLC, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, Manatuck Hill Partners, LLC, TWO SIGMA INVESTMENTS, LP, Anson Funds Management LP, and TWO SIGMA ADVISERS, LP.
This table shows 34 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.